VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH CML 2022 | The use of miRNAs as predictive biomarkers in CML

Andrew Wu, BS, MS, British Columbia Cancer Agency, Vancouver, Canada, comments on the use of microRNAs (miRNAs) as predictive biomarkers at diagnosis and post-treatment in chronic myeloid leukemia (CML), highlighting the challenges associated with using miRNAs as biomarkers. This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter